Predictors and patterns of red blood cell transfusion use among newly diagnosed cancer patients with chemotherapy-associated anemia in Western Denmark (1998–2003)

by Mellissa Yong, Anders H. Riis, Jon P. Fryzek, et al
Published 2011-03-01

The incidence of infusion reactions associated with monoclonal antibody drugs targeting the epidermal growth factor receptor in metastatic colorectal cancer patients: A systematic...

by Lauren C. Bylsma, Rebecca Dean, Kimberly Lowe, Laura Sangaré, Dominik D. Alexander, Jon P. Fryzek
Published 2019-09-01

Indirect treatment comparison of cabazitaxel for patients with metastatic castrate-resistant prostate cancer who have been previously treated with a docetaxel-containing regimen.

by Jon P Fryzek, Heidi Reichert, Nicholas Summers, Lindsay Townes, Robert Deuson, Dominik D Alexander, Jackie Vanderpuye-Orgle
Published 2018-01-01

Increased risk of thrombotic events in cold agglutinin disease: A 10‐year retrospective analysis

by Catherine M. Broome, Julia M. Cunningham, Megan Mullins, Xiaohui Jiang, Lauren C. Bylsma, Jon P. Fryzek, Adam Rosenthal
Published 2020-05-01

Prevalence of RAS and BRAF mutations in metastatic colorectal cancer patients by tumor sidedness: A systematic review and meta‐analysis

by Lauren C. Bylsma, Christina Gillezeau, Tamer A. Garawin, Michael A. Kelsh, Jon P. Fryzek, Laura Sangaré, Kimberly A. Lowe
Published 2020-02-01